The IPO Buzz: Maze Therapeutics Sets Terms & Launches $124.8 Million IPO (Corrected)
Chronic kidney disease-focused Maze Therapeutics (MAZE Proposed) disclosed the terms for its $124.8 million IPO early today – Monday, Jan. 27, 2025 – and launched the deal to price this week. Maze Therapeutics plans to offer 7.8 million shares at a price range of $15.00 to $17.00 to raise $124.8 million, if priced at the […]
January 27, 2025 Read More